Elastofibroma dorsi: What’s new?

  • Maria Serena Oliva Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Catholic University of the Sacred Heart, Rome, Italy.
  • Alessandro Smimmo Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Catholic University of the Sacred Heart, Rome, Italy.
  • Raffaele Vitiello | lele.vitiello@gmail.com Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Catholic University of the Sacred Heart, Rome, Italy.
  • Cesare Meschini Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Catholic University of the Sacred Heart, Rome, Italy.
  • Francesco Muratori Oncologic and Reconstructive Orthopedic Surgery, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
  • Giulio Maccauro Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; Catholic University of the Sacred Heart, Rome, Italy.
  • Antonio Ziranu Department of Orthopedics and Traumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Abstract

Elastofibroma dorsi is a rare slowgrowing soft tissues tumor. The lesion usually grows near the shoulder but could also involve other location. Pathogenesis of elastofibroma dorsi is still unknown and in the literature, there are mostly described case report or case series. The aim of our study is to summarize the recent innovation in the histology and immunoistochemical finding about elastofibroma and update the radiological algorithm of diagnosis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1. Jarvi O, Saxen E. Elastofibroma dorse. Acta Pathol Microbiol Scand Suppl. 1961;51:83–4.
2. Bartocci M, Dell’Atti C, Meacci E, et al. Clinical features, imaging findings, treatment aspects of elastofibroma dorsi and long-term outcomes after surgical resection. Eur Rev Med Pharmacol Sci. 2017;21:2061–8.
3. Hayes AJ, Alexander N, Clark MA, Thomas JM. Elastofibroma: a rare soft tissue tumour with a pathognomonic anatomical location and clinical symptom. Eur J Surg Oncol. 2004;30:450–3.
4. Daigeler A, Vogt PM, Busch K, et al. Elastofibroma dorsi--differential diagnosis in chest wall tumours. World J Surg Oncol. 2007 5;5:15.
5. Abe S, Miyata N, Yamamoto Y, et al. Elastofibroma dorsi: CT, MRI, and pathologic findings. Plast Reconstr Surg. 1999;104:2121–6.
6. Yu JS, Weis LD, Vaughan LM, Resnick D. MRI of elastofibroma dorsi. J Comput Assist Tomogr. 1995 ;19:601–3.
7. Tsubakimoto M, Yamashiro T, Tsuchiya N, et al. MRI findings and demographics of elastofibroma dorsi: assessment of diffusion-weighted imaging and contrast enhancement patterns. Acta Radiol. 2018;59:709–15.
8. Erhamamci S, Reyhan M, Nursal GN, et al. Elastofibroma dorsi incidentally detected by (18)F-FDG PET/CT imaging. Ann Nucl Med. 2015;29:420–5.
9. Kakudo N, Morimoto N, Ogawa T, et al. Elastofibroma dorsi: a case report with an immunohistochemical and ultrastructural studies. Med Mol Morphol. 2016;49:42–7.
10. Temel U, Gül Akgül A, Topçu S. Diffusion MR: A New Diagnostic Tool for Elastofibroma Dorsi. Sisli Etfal Hastan Tip Bul. 2020;54:103–7.
11. Findikcioglu A, Kilic D, Karadayi Ş, et al. A thoracic surgeon’s perspective on the elastofibroma dorsi: A benign tumor of the deep infrascapular region. Thorac Cancer. 2013;4:35–40.
12. Harigopal M, Seshan SV, DeLellis RA, et al. Aspiration cytology of elastofibroma dorsi: case report with ultrastructural and immunohistochemical findings. Diagn Cytopathol. 2002;26:310–3.
13. De Weerdt G, Verhoeven V, Vrints I, et al. Elastofibroma dorsi: a case report of bilateral occurrence and review of literature. Acta Chir Belg. 2019 16;1–5.
14. Novati FC, Franchi A, Papa G, Arnež ZM. Elastofibroma dorsi. Our experience with 11 lesions. Ann Ital Chir. 2014 29;85.
15. Nakamura Y, Ohta Y, Itoh S, et al. Elastofibroma dorsi. Cytologic, histologic, immunohistochemical and ultrastructural studies. Acta Cytol. 1992;36:559–62.
16. Ziranu A, Lillo M, Fantoni M, et al. Single dose cefazolin is safe and effective for pre-operative prophylaxis in orthopaedic oncology. J Biol Regul Homeost Agents. 2018;32:45–9.
17. Muratori F, Esposito M, Rosa F, et al. Elastofibroma dorsi: 8 case reports and a literature review. J Orthop Traumatol. 2008;9:33–7.
18. Yamazaki K. An ultrastructural and immunohistochemical study of elastofibroma: CD 34, MEF-2, prominin 2 (CD133), and factor XIIIa-positive proliferating fibroblastic stromal cells connected by Cx43-type gap junctions. Ultrastruct Pathol. 2007;31:209–19.
19. Kuroda N, Hamaguchi N, Ohara M, et al. Elastofibroma: a histochemical, immunohistochemical, and ultrastructural study of two patients. Med Mol Morphol. 2008;41:179–82.
20. D’Adamio S, Cazzato G, Ziranu A, et al. Soft tissue adhesion patterns over Trevira tube on modular endoprosthesis for malignant bone tumours: an in vitro study. J Biol Regul Homeost Agents. 2017;31:37–42.
21. Hemmi A, Tabata M, Homma T, et al. Application of a quick-freezing and deep-etching method to pathological diagnosis: a case of elastofibroma. J Electron Microsc (Tokyo). 2006;55:89–95.
22. Silverman JS, Tamsen A. Fibrohistiocytic differentiation in subcutaneous fatty tumors. Study of spindle cell, pleomorphic, myxoid, and atypical lipoma and dedifferentiated liposarcoma cases composed in part of CD34+ fibroblasts and FXIIIa+ histiocytes. J Cutan Pathol. 1997;24:484–93.
23. Park PW, Biedermann K, Mecham L, et al. Lysozyme binds to elastin and protects elastin from elastase-mediated degradation. J Invest Dermatol. 1996;106:1075–80.
24. Ramos CV, Gillespie W, Narconis RJ. Elastofibroma. A pseudotumor of myofibroblasts. Arch Pathol Lab Med. 1978;102:538–40.
25. Di Vito A, Scali E, Ferraro G, et al. Elastofibroma dorsi: a histochemical and immunohistochemical study. Eur J Histochem. 2015 19;59:2459.
26. Tete S, Tripodi D, Rosati M, et al. Role of mast cells in innate and adaptive immunity. J Biol Regul Homeost Agents. 2012;26:193–201.
27. Benisch B, Peison B, Marquet E, Sobel HJ. Pre-elastofibroma and elastofibroma (the continuum of elastic-producing fibrous tumors). A light and ultrastructural study. Am J Clin Pathol. 1983;80:88–92.
28. Cota C, Solivetti F, Kovacs D, et al. Elastofibroma dorsi: histologic and echographic considerations. Int J Dermatol. 2006;45:1100–3.
29. Magarelli N, Carducci C, Bucalo C, et al. Sonoelastography for qualitative and quantitative evaluation of superficial soft tissue lesions: a feasibility study. Eur Radiol. 2014;24:566–73.
30. Davidson T, Goshen E, Eshed I, et al Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans. Nucl Med Commun. 2016;37:837–42.
31. Kind M, Stock N, Coindre JM. Histology and imaging of soft tissue sarcomas. Eur J Radiol. 2009;72:6–15.
32. Bancroft LW, Pettis C, Wasyliw C. Imaging of benign soft tissue tumors. Semin Musculoskelet Radiol. 2013;17:156–67.
Published
2020-07-01
Keywords:
elastofibroma; soft tissue; tumor; histology
Statistics
  • Abstract views: 32

  • PDF: 15
How to Cite
Oliva, M. S., Smimmo, A., Vitiello, R., Meschini, C., Muratori, F., Maccauro, G., & Ziranu, A. (2020). Elastofibroma dorsi: What’s new?. Orthopedic Reviews, 12(1s). https://doi.org/10.4081/or.2020.8708